An advanced broad-spectrum antibiotic combining Amoxicillin 500mg and Clavulanic Acid 125mg — formulated for effective treatment of dental, respiratory and bacterial infections. Manufactured by Trunexora Healthcare
GOBACTO™-625 Tablet is a prescription-only antibiotic developed by Trunexora Healthcare for the management of moderate to severe bacterial infections. It combines the proven efficacy of Amoxicillin (a penicillin-class antibiotic) with Clavulanic Acid (a beta-lactamase inhibitor) — making it effective against beta-lactamase producing resistant bacteria.
GOBACTO™-625 is widely prescribed across dental, respiratory, ENT, urinary and soft tissue infections, offering comprehensive bacterial coverage with a well-established safety profile.
Effective against both gram-positive and gram-negative bacteria.
Clavulanic Acid inhibits beta-lactamase enzymes.
Quick absorption for rapid therapeutic action.
Well-established efficacy with predictable safety profile.
| Product Name | GOBACTO™- 625 Tablet |
|---|---|
| Brand | GOBACTO™ |
| Category | Antibiotic |
| Pack Size | Strip of 10 tablets |
| Composition | Amoxicillin 500 mg + Clavulanic Acid 125 mg. |
| Dosage | One tablet every 12 hours after food, or as prescribed. Complete the full course. |
| Manufacturer | Trunexora Healthcare |
| Certification | GLP/GMP Certified |
This information is for general awareness only and is not a substitute for professional medical advice. Please consult your dentist or physician before starting any medication or treatment.